3PBiovian

3PBIOVIAN strengthens its leadership team with the appointment of a Business Development Director for Advanced Therapies

This strategic hire will further solidify 3PBIOVIAN’s position as a leading CDMO in the development of advanced therapies and enhance its international commercial team October 9, 2024 – Noáin, Spain– 3PBIOVIAN, a leading contract development and manufacturing organization (CDMO), announces the appointment of Almira Bartolomé as Business Development Director for Advanced Therapies, reporting to Elena...

3PBIOVIAN strengthens its leadership team with the appointment of a Business Development Director for Advanced Therapies

This strategic hire will further solidify 3PBIOVIAN’s position as a leading CDMO in the development of advanced therapies and enhance its international commercial team 9 October 2024 -- Noáin, Spain -- 3PBIOVIAN, a leading contract development and manufacturing organization (CDMO), announces the appointment of Almira Bartolomé as Business Development Director for Advanced Therapies, reporting to...

3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN,a leading pan-European biologics CDMO

1 February 2024 – Paris, France – Biovian and 3P Biopharmaceuticals (“3P”), two leading biologics Contract Development and Manufacturing Organisations (CDMOs), announced today their combination to establish a new pan-European leader in their field. Backed by their common shareholder, Keensight Capital, one of the leading private equity funds dedicated to pan-European Growth Buyout investments, the...